Literature DB >> 11294378

Clinical research: the influence of the pharmaceutical industry.

O P Hole1, F O Winther, B Straume.   

Abstract

OBJECTIVE: The aim of the investigation is to throw light on the influence of the pharmaceutical industry on clinical research in Norway. The files of the five regional medical research ethics committees, which contain the application forms and the protocols of all the research projects on humans, were used as source for the statistics. The projects were first classified and registered in two groups: pharmacology/pharmacotherapy and others. Then the pharmacology/pharmacotherapy group was divided into projects sponsored or initiated by the industry and others.
RESULTS: In the 3 years 1988-1990, the yearly average number of projects was 360. Sixty-two percent of the projects were pharmacology/pharmacotherapy; seventy-nine percent of these projects were conducted by the industry. The corresponding figures for the year 1997 were 747, 40% and 68%, respectively. We have not been able to find similar statistics from other countries.
CONCLUSION: Our conclusion is that research in pharmacology/pharmacotherapy should be more independent of industry.

Entities:  

Mesh:

Year:  2001        PMID: 11294378     DOI: 10.1007/s002280000238

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.

Authors:  Finn O Winther; Ola P Hole; Sigurd Nitter-Hauge
Journal:  Eur J Clin Pharmacol       Date:  2007-08-03       Impact factor: 2.953

2.  An analysis of the clinical development of drugs in Norway for the year 2000: the completion of research and publication of results.

Authors:  Ola P Hole; Sigurd Nitter-Hauge; Henrik R Cederkvist; Finn O Winther
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

3.  Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.

Authors:  Joel Lexchin
Journal:  Sci Eng Ethics       Date:  2011-02-15       Impact factor: 3.525

Review 4.  Ethics in exercise science research.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

5.  Clinical drug trials in general practice: a 10-year overview of protocols.

Authors:  Anja Maria Brænd; Kaspar Buus Jensen; Atle Klovning; Jørund Straand
Journal:  Trials       Date:  2013-06-01       Impact factor: 2.279

Review 6.  Clinical Approach to the Therapy of Asthma-COPD Overlap.

Authors:  Diego J Maselli; Megan Hardin; Stephanie A Christenson; Nicola A Hanania; Craig P Hersh; Sandra G Adams; Antonio Anzueto; Jay I Peters; MeiLan K Han; Fernando J Martinez
Journal:  Chest       Date:  2018-08-02       Impact factor: 10.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.